Ovid Therapeutics Inc. announced that it will receive $25,861,228 in a round of equity funding on January 6, 2017. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.055 USD | +1.44% |
|
+21.19% | -67.11% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-67.11% | 73.78M | |
+18.41% | 126B | |
+23.18% | 118B | |
+23.52% | 27.87B | |
-18.11% | 20.95B | |
-15.13% | 16.92B | |
-14.68% | 16.18B | |
+9.20% | 14.84B | |
-46.10% | 14.79B | |
+52.54% | 14.08B |
- Stock Market
- Equities
- OVID Stock
- News Ovid Therapeutics Inc.
- Ovid Therapeutics Inc. announced that it expects to receive $25.86 million in funding from Takeda Pharmaceutical Company Limited